148 related articles for article (PubMed ID: 36367476)
21. Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.
Lin YC; Wu MH; Wei TT; Chuang SH; Chen KF; Cheng AL; Chen CC
Neoplasia; 2012 Jun; 14(6):463-75. PubMed ID: 22787428
[TBL] [Abstract][Full Text] [Related]
22. Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response.
Korpela SP; Hinz TK; Oweida A; Kim J; Calhoun J; Ferris R; Nemenoff RA; Karam SD; Clambey ET; Heasley LE
J Transl Med; 2021 Jan; 19(1):43. PubMed ID: 33485341
[TBL] [Abstract][Full Text] [Related]
23. A small molecule nanodrug consisting of pH-sensitive ortho ester-dasatinib conjugate for cancer therapy.
Gao J; Qiao Z; Liu S; Xu J; Wang S; Yang X; Wang X; Tang R
Eur J Pharm Biopharm; 2021 Jun; 163():188-197. PubMed ID: 33864903
[TBL] [Abstract][Full Text] [Related]
24. Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.
Bauman JE; Duvvuri U; Gooding WE; Rath TJ; Gross ND; Song J; Jimeno A; Yarbrough WG; Johnson FM; Wang L; Chiosea S; Sen M; Kass J; Johnson JT; Ferris RL; Kim S; Hirsch FR; Ellison K; Flaherty JT; Mills GB; Grandis JR
JCI Insight; 2017 Mar; 2(6):e90449. PubMed ID: 28352657
[No Abstract] [Full Text] [Related]
25. Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma.
Zhang L; Zhang W; Wang YF; Liu B; Zhang WF; Zhao YF; Kulkarni AB; Sun ZJ
Cell Death Dis; 2015 May; 6(5):e1771. PubMed ID: 26018732
[TBL] [Abstract][Full Text] [Related]
26. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
27. Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma.
Ryumon S; Okui T; Kunisada Y; Kishimoto K; Shimo T; Hasegawa K; Ibaragi S; Akiyama K; Thu Ha NT; Monsur Hassan NM; Sasaki A
Oncol Rep; 2019 Dec; 42(6):2611-2621. PubMed ID: 31638244
[TBL] [Abstract][Full Text] [Related]
28. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
[TBL] [Abstract][Full Text] [Related]
29. Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.
Zhao C; Zhou X; Cao Z; Ye L; Cao Y; Pan J
Phytomedicine; 2023 Oct; 119():154986. PubMed ID: 37506572
[TBL] [Abstract][Full Text] [Related]
30. CTLA-4 blockade induces tumor pyroptosis via CD8
Wang S; Wu ZZ; Zhu SW; Wan SC; Zhang MJ; Zhang BX; Yang QC; Xiao Y; Li H; Mao L; Wang ZY; Gutkind JS; Sun ZJ
Mol Ther; 2023 Jul; 31(7):2154-2168. PubMed ID: 36869589
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion.
Sarnella A; Ferrara Y; Auletta L; Albanese S; Cerchia L; Alterio V; De Simone G; Supuran CT; Zannetti A
J Exp Clin Cancer Res; 2022 Apr; 41(1):122. PubMed ID: 35365193
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition.
Ban MJ; Byeon HK; Yang YJ; An S; Kim JW; Kim JH; Kim DH; Yang J; Kee H; Koh YW
Cancer Sci; 2018 Dec; 109(12):3816-3825. PubMed ID: 30343534
[TBL] [Abstract][Full Text] [Related]
33. C188-9, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma.
Di JX; Zhang HY
Anticancer Drugs; 2019 Sep; 30(8):846-853. PubMed ID: 30870229
[TBL] [Abstract][Full Text] [Related]
34. Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.
Nozawa H; Howell G; Suzuki S; Zhang Q; Qi Y; Klein-Seetharaman J; Wells A; Grandis JR; Thomas SM
Clin Cancer Res; 2008 Jul; 14(13):4336-44. PubMed ID: 18594017
[TBL] [Abstract][Full Text] [Related]
35. Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy.
Huang X; Han L; Wang R; Zhu W; Zhang N; Qu W; Liu W; Liu F; Feng F; Xue J
Drug Deliv; 2022 Dec; 29(1):1358-1369. PubMed ID: 35506467
[TBL] [Abstract][Full Text] [Related]
36. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
Stauber RH; Knauer SK; Habtemichael N; Bier C; Unruhe B; Weisheit S; Spange S; Nonnenmacher F; Fetz V; Ginter T; Reichardt S; Liebmann C; Schneider G; Krämer OH
Oncotarget; 2012 Jan; 3(1):31-43. PubMed ID: 22289787
[TBL] [Abstract][Full Text] [Related]
37. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.
Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR
Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227
[TBL] [Abstract][Full Text] [Related]
38. Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy.
Wan SC; Ye MJ; Yang QC; Zhang T; Zhang MJ; Ma XB; Xu JM; Wang S; Wu ZZ; Yang LL; Shen XM; Xu Z; Sun ZJ
Adv Healthc Mater; 2023 Mar; 12(7):e2202135. PubMed ID: 36479643
[TBL] [Abstract][Full Text] [Related]
39. Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma.
Kwon M; Nam GH; Jung H; Kim SA; Kim S; Choi Y; Lee YS; Cho HJ; Kim IS
Cancer Lett; 2021 Dec; 522():198-210. PubMed ID: 34571082
[TBL] [Abstract][Full Text] [Related]
40. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
